Module 0 - Introduction

Introduction

0.3

Multidrug-Resistant Tuberculosis (MDR-TB)

MDR-TB treatment is less successful than treatment for drug sensitive TB due to the need to use drugs that:
- Are less efficacious
- Are often bacteriostatic
- Have significant toxicity profiles
- Are used for long periods of time
The cost of treatment is often prohibitive as well.
MDR-TB treatment outcomes have varied greatly depending on the setting and patient characteristics but globally less than half of patients treated were cured.